Dr. Arnoldas Ceponis, MD

Dr. Ceponis practices at Kern County Hospital Authority in Bakersfield, California.

Dr. Ceponis' NPI, 1144423039, was assigned on June 7, 2007. Dr. Ceponis graduated from Kaunas Medical Institute in 1989. Dr. Ceponis holds California license A106525.

Dr. Ceponis' primary practice is Kern County Hospital Authority, at 1700 Mt Vernon Ave, Bakersfield, CA 93306 in Kern County. The practice phone is (661) 326-2000.

Dr. Ceponis' primary practice is Kern County Hospital Authority in Bakersfield, California. Dr. Ceponis is also affiliated with Adventist Health Bakersfield. The medical group on file is Kern Medical. Dmand AI also links Dr. Ceponis to 3 more hospitals and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ceponis practices, 4 sites in all. Vendor and product names are available with a free account.

Rheumatology is Dr. Ceponis' primary specialty in the NPI Registry, under taxonomy code 207RR0500X. Dr. Ceponis is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Ceponis' licenses on file in 3 states: California, Michigan and Montana.

Dmand AI lists arteritis, arthritis, fluid in a joint, gout, joint arthropathy, joint pain, lupus and muscle pain, fibromyalgia, and limb pain among the conditions Dr. Ceponis treats.

CMS data shows 1,117 Medicare services from Dr. Ceponis across 7 procedure codes in 2024, for 263 Medicare patients. Medicare paid $51,953 for them.

CMS counts 263 Medicare patients who saw Dr. Ceponis in 2024. The largest group is 65 to 74, with 109 patients. 75% of them have arthritis, and 70% have high blood pressure. 34% are also on Medicaid. Their average risk score is 1.74, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Ceponis' median patient age at 60, with 76% women.

In 2024, Dr. Ceponis wrote 2,390 Medicare Part D claims for 242 patients. 72% of them were for generic drugs. CMS names the drug for 2,157 of them, across 42 drugs with 11 or more claims each, at $3,485,649 in total drug cost. In 2023, CMS named 2,059 claims across 41 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Dr. Ceponis for performance year 2024, reported as part of a group. Dr. Ceponis accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Ceponis as offering telehealth.

Dmand AI links 9 papers to Dr. Ceponis, published from 2010 to 2023. The most frequent topics are Synovial Membrane, Synovitis and Arthritis. Dr. Ceponis has published most often in Haemophilia. Dr. Ceponis' most frequent co-authors are Jennifer H. Anolik, MD, Ami Ben-Artzi, MD and Vivian Patricia Bykerk, MD.

CMS Open Payments shows 19 general payments to Dr. Ceponis from 9 drug and device companies from 2016 to 2024. Grants make up the largest share, 97% of the total. Abbvie Inc. paid the most, $12,076.

Dmand AI lists 2 awards for Dr. Ceponis, most recently CMS Stage 1 EHR in 2013.

Dr. Ceponis graduated from Kaunas Medical Institute in 1989. Dr. Ceponis is a member of ACR.

Dr. Ceponis is in network with 15 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.